SNP ID | Position | Alleles | Trait | Variation Type |
---|---|---|---|---|
rs17165697 | chr7:88951002 (GRCh38.p7) | G>A | alcohol dependence | SNV(Single Nucleotide Variation) |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
COL19A1 | 0.742 |
KCNH7 | 0.734 |
GRM5 | 0.723 |
TRPC5 | 0.723 |
CNTNAP5 | 0.72 |
SYT10 | 0.708 |
CDKL5 | 0.702 |
PCDHAC1 | 0.701 |
NYAP2 | 0.689 |
GABRG3 | 0.685 |
Gene Symbol | Pearson Correlation Coefficient |
---|---|
IMPA2 | -0.46 |
AGTRAP | -0.436 |
ROM1 | -0.435 |
RAB13 | -0.433 |
NBPF10 | -0.43 |
PLIN2 | -0.425 |
TGIF1 | -0.424 |
MT1M | -0.417 |
RAB20 | -0.413 |
GNG5 | -0.413 |
ID | Drug Name | Action | PubMed |
---|---|---|---|
C039674 | 2,3,4,5-tetrachlorophenate | "ZNF804B gene SNP affects the susceptibility to 2,3,4,5-tetrachlorophenate" | 25622337 |
D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased methylation of ZNF804B gene | 27153756 |
C547126 | AZM551248 | AZM551248 results in increased expression of ZNF804B mRNA | 22323515 |
D014635 | Valproic Acid | Valproic Acid results in decreased methylation of ZNF804B gene | 29154799 |
D015034 | Zinc Oxide | Zinc Oxide analog results in decreased expression of ZNF804B mRNA | 27215404 |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|---|---|---|---|
GO:0003676 | nucleic acid binding | - | IEA | - |
GO:0046872 | metal ion binding | - | IEA | - |
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|
GO ID | GO Term | Qualifier | Evidence | PubMed |
---|
KEGG ID | KEGG Term |
---|
Reactome ID | Reactome Term | Evidence |
---|---|---|
R-HSA-212436 | Generic Transcription Pathway | TAS |
R-HSA-73857 | RNA Polymerase II Transcription | TAS |
R-HSA-74160 | Gene expression (Transcription) | TAS |
PMID | Title (Year) | Author | Journal |
---|